Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Disparate outcomes in nonsmall cell lung cancer by immigration status.
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Disparate outcomes in nonsmall cell lung cancer by immigration status.
Disparate outcomes in nonsmall cell lung cancer by immigration status. Cancer Med. 2021 04; 10(8):2660-2667.
View in:
PubMed
subject areas
Aged
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Combined Modality Therapy
Emigration and Immigration
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Prognosis
Retrospective Studies
Socioeconomic Factors
Survival Rate
authors with profiles
Ravi Salgia